Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DR26FCN8M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,463
Award facts
- Contract value 100% obligated
- $17,463.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $17,463.41 on November 12, 2025, for the supply of Renflexis 100 mg vials. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by November 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and related medical commodities. As a child delivery order under this prime indefinite delivery vehicle, this award for Renflexis (infliximab biosimilar) contributes to the DLA's ongoing pharmaceutical supply chain for defense health operations.
Quick answers
Who was awarded contract SPE2DR26FCN8M?
SPE2DR26FCN8M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FCN8M worth?
The government has obligated $17,463 on SPE2DR26FCN8M.
Is contract SPE2DR26FCN8M an order under another contract?
Yes. SPE2DR26FCN8M is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCN8M competed?
The extent of competition for SPE2DR26FCN8M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award